Text of AZ SB 1138 (2022)
Irreversible gender reassignment surgery; minors
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
18,594 characters
REFERENCE TITLE: gender transition;
prohibitions; public monies
State of
Arizona
Senate
Fifty-fifth
Legislature
Second Regular
Session
2022
SB 1138
Introduced by
Senator Petersen
AN ACT
AMENDING TITLE 32, CHAPTER 32, ARTICLE 1,
ARIZONA REVISED STATUTES, BY ADDING SECTION 32-3230; RELATING TO HEALTH
PROFESSIONALS.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 32, chapter 32, article 1,
Arizona Revised Statutes, is amended by adding section 32-3230, to read:
START_STATUTE32-3230. Prohibition of gender transition procedures for minors; public
monies prohibited; enforcement; definitions
A. A physician or other health care
professional may not provide gender transition procedures to any individual who
is under eighteen years of age. A physician or other health care
professional may not refer any individual who is under eighteen years of age to
any health care professional for gender transition procedures. A
physician or other health care professional is not prohibited from providing
any of the following procedures that are not gender transition procedures to an
individual who is under eighteen years of age:
1. Services to persons born with a
medically verifiable disorder of sex development, including a person with
external biological sex characteristics that are irresolvably ambiguous, such
as being born with forty-six XX chromosomes with virilization or forty-six XY
chromosomes with undervirilization or having both ovarian and testicular
tissue.
2. Services provided when a physician
has otherwise diagnosed a disorder of sexual development and has determined
through genetic or biochemical testing that the person does not have normal sex
chromosome structure, sex steroid hormone production or sex steroid hormone
action.
3. The treatment of any infection,
injury, disease or disorder that has been caused by or exacerbated by the
performance of gender transition procedures, whether or not the gender
transition procedure was performed in accordance with state and federal law or
whether or not funding for the gender transition procedure is allowable under
this section.
4. Any procedure undertaken because
the individual suffers from a physical disorder, physical injury or physical
illness that would, as certified by a physician, place the individual in
imminent danger of death or impairment of major bodily function unless surgery
is performed.
B. Public monies may not be directly
or indirectly used, granted, paid or distributed to any entity, organization or
individual that provides gender transition procedures to an individual who is
under eighteen years of age. Health care services furnished in the
following situations may not include gender transition procedures to an
individual who is under eighteen years of age:
1. By or in a health care facility
owned by this state or a county or local government.
2. By a physician or other health
care professional employed by the state or a county or local government.
C. Any
amount paid by an individual or an entity during a taxable year for gender
transition procedures or as premiums for health care coverage that includes
coverage for gender transition procedures is not tax-deductible.
D. The Arizona health care cost
containment system may not reimburse or provide coverage for gender transition
procedures to an individual who is under eighteen years of age.
E. Any referral for or provision of
gender transition procedures to an individual who is under eighteen years of
age is unprofessional conduct and is subject to discipline by the appropriate
licensing entity or health profession regulatory board.
F. A person may assert an actual or
threatened violation of this section as a claim or defense in a judicial or
administrative proceeding and obtain compensatory damages, injunctive relief,
declaratory relief or any other appropriate relief. A person shall
bring a claim for a violation of this section not later than two years after
the day the cause of action accrues. An individual who is under
eighteen years of age may bring an action throughout the individual's minority
through a parent or next friend and may bring an action in the individual's own
name on reaching eighteen years of age until twenty years after reaching the
eighteen years of age.
G. Notwithstanding any other law, an
action under this section may be commenced, and relief may be granted, in a
judicial proceeding without regard to whether the person commencing the action
has sought or exhausted available administrative remedies. In any
action or proceeding to enforce this section, a prevailing party who establishes
a violation of this section shall recover reasonable attorney fees.
H. The attorney general may bring an
action to enforce compliance with this section. This section does
not deny, impair or otherwise affect any right or authority of the attorney
general, this state or any agency, officer or employee of this state, acting
under any law other than this section, to institute or intervene in any
proceeding.
I. A health benefits plan under an
insurance policy or other plan providing health care coverage in this state may
not include reimbursement for gender transition procedures for a person who is
under eighteen years of age. A health benefits plan under an
insurance policy or other plan providing health care coverage in this state is
not required to provide coverage for gender transition procedures.
J. For the purposes of this section:
1. "Biological sex" means
the biological indication of male and female in the context of reproductive
potential or capacity, such as sex chromosomes, naturally occurring sex hormones,
gonads and nonambiguous internal and external genitalia present at birth,
without regard to an individual's psychological, chosen or subjective
experience of gender.
2. "Cross-sex
hormones" means either of the following:
(a) Testosterone
or other androgens given to biological females in amounts that are larger or
more potent than would normally occur naturally in healthy biological sex
females.
(b) Estrogen
given to biological males in amounts that are larger or more potent than would
normally occur naturally in healthy biological sex males.
3. "Gender" means the
psychological, behavioral, social and cultural aspects of being male or female.
4. "Gender reassignment
surgery":
(a) Means any
medical or surgical service that seeks to surgically alter or remove healthy
physical or anatomical characteristics or features that are typical for an
individual's biological sex in order to instill or create physiological or
anatomical characteristics that resemble a sex different from the individual's
biological sex.
(b) Includes
genital or nongenital gender reassignment surgery performed for the purpose of
assisting an individual with a gender transition.
5. "Gender transition"
means the process in which a person goes from identifying with and living as a
gender that corresponds to the person's biological sex to identifying with and
living as a gender different from the person's biological sex and may involve
social, legal or physical changes.
6. "Gender transition
procedures":
(a) Means any
medical or surgical service, including physician services, inpatient and
outpatient hospital services or prescribed drugs related to gender transition,
that seeks to either:
(i) Alter or
remove physical or anatomical characteristics or features that are typical for
the individual's biological sex.
(ii) Instill or
create physiological or anatomical characteristics that resemble a sex
different from the individual's biological sex, including medical services that
provide puberty-blocking drugs, cross-sex hormones or other mechanisms to
promote the development of feminizing or masculinizing features in the opposite
biological sex or genital or nongenital gender reassignment surgery performed
for the purpose of assisting an individual with a gender transition.
(b) Does not
include any of the following:
(i) Services to
persons born with a medically verifiable disorder of sex development, including
a person with external biological sex characteristics that are irresolvably
ambiguous, such as being born with forty-six XX chromosomes with virilization
or forty-six XY chromosomes with undervirilization or having both ovarian and
testicular tissue.
(ii) Services provided when a physician has otherwise
diagnosed a disorder of sexual development and has determined through genetic
or biochemical testing that the person does not have normal sex chromosome
structure, sex steroid hormone production or sex steroid hormone action.
(iii) The
treatment of any infection, injury, disease or disorder that has been caused by
or exacerbated by the performance of gender transition procedures, whether or
not the gender transition procedure was performed in accordance with state and
federal law or whether not funding for the gender transition procedure is
allowable under this section.
(iv) Any
procedure undertaken because the individual suffers from a physical disorder,
physical injury or physical illness that would, as certified by a physician,
place the individual in imminent danger of death or impairment of major bodily
function unless surgery is performed.
7. "Genital gender reassignment
surgery" means a medical procedure performed for the purpose of assisting
an individual with a gender transition, including any of the following:
(a) Surgical
procedures such as penectomy, orchiectomy, vaginoplasty, clitoroplasty or
vulvoplasty for biologically male patients or hysterectomy or ovariectomy for
biologically female patients.
(b) Reconstruction
of the fixed part of the urethra with or without a metoidioplasty.
(c) Phalloplasty,
vaginectomy, scrotoplasty or implantation of erection or testicular prostheses
for biologically female patients.
8. "Health care
professional" means a health professional as defined in section 32-3201.
9. "Nongenital gender
reassignment surgery" means medical procedures performed for the purpose
of assisting an individual with a gender transition, including either of the
following:
(a) Surgical
procedures for biologically male patients, such as augmentation mammoplasty,
facial feminization surgery, liposuction, lipofilling, voice surgery, thyroid
cartilage reduction, gluteal augmentation, hair reconstruction or various
aesthetic procedures.
(b) Surgical
procedures for biologically female patients, such as subcutaneous mastectomy,
voice surgery, liposuction, lipofilling, pectoral implants or various aesthetic
procedures.
10. "Physician" means a
person who is licensed pursuant to chapter 13 or 17 of this title.
11. "Puberty-blocking
drugs" means gonadotropin-releasing hormone analogues or other synthetic
drugs used in biological males to stop luteinizing hormone secretion and
testosterone secretion, or synthetic drugs used in biological females which
stop the production of estrogens and progesterone, when used to delay or
suppress pubertal development in children for the purpose of assisting an
individual with a gender transition.
12. "Public monies" means
state, county or local government monies, in addition to any department, agency
or instrumentality authorized or appropriated under state law or derived from
any fund in which such monies are deposited. END_STATUTE
Sec. 2. Legislative right
of intervention
The legislature, by joint resolution, may appoint one or more
of its members who sponsored or cosponsored this act in the member's official
capacity to intervene or defend the statute as a matter of right in any case in
which the constitutionality or enforceability of this act or any portion of
this act or any rule adopted pursuant to this act is challenged.
Sec. 3. Legislative
findings
The legislature finds that:
1. Arizona has a compelling governmental interest in
protecting the health and safety of its citizens, especially vulnerable
children.
2. Only a small percentage of the American
population experiences distress at identifying with their biological sex.
3. For the small percentage of children who are
gender-nonconforming or who experience distress at identifying with their
biological sex, studies consistently demonstrate that the majority come to
identify with their biological sex in adolescence or adulthood, thereby
rendering most physiological interventions unnecessary.
4. Furthermore, scientific studies show that
individuals experiencing distress at identifying with their biological sex
often experienced psychopathology preceding their gender dysphoria, which
indicates these individuals should be encouraged to seek mental health
services.
5. Even among people who have undergone inpatient
gender reassignment procedures, suicide rates, psychiatric morbidities and
mortality rates remain markedly elevated above the background population.
6. Some healthcare providers are prescribing
puberty-blocking drugs, such as gonadotropin-releasing hormone analogues, in
order to delay the onset or progression of puberty in children who experience
distress at identifying with their biological sex. Puberty-blocking
drugs are being prescribed despite the lack of any long-term longitudinal
studies evaluating the risks and benefits of using these drugs for the
treatment of such distress or gender transition.
7. Health care providers are also prescribing
cross-sex hormones for children who experience distress at identifying with
their biological sex, despite the fact that no randomized clinical trials have
been conducted on the efficacy or safety of the use of cross-sex hormones in
adults or children for the purpose of treating such distress or gender
transition.
8. The use of
cross-sex hormones comes with serious known risks, such as:
(a) For biological
females:
(i) Erythrocytosis, which is an increase in red
blood cells.
(ii) Severe liver dysfunction.
(iii) Coronary artery disease, including heart
attacks.
(iv) Cerebrovascular disease, including strokes.
(v) Hypertension.
(vi) Increased risk of breast and uterine cancers.
(vii) Irreversible infertility.
(b) For biological males.
(i) Thromboembolic disease, including blood clots.
(ii) Cholelithiasis, including gallstones.
(iii) Coronary artery disease, including heart
attacks.
(iv) Macroprolactinoma, which is a tumor of the
pituitary gland.
(v) Cerebrovascular disease, including strokes.
(vi) Hypertriglyceridemia, which is an elevated
level of tryglycerides in the blood.
(vii) Breast cancer.
(viii) Irreversible infertility.
9. Genital and nongenital gender reassignment
surgeries are generally not recommended for children, although evidence
indicates referrals for children to have such surgeries are becoming more frequent.
10. Genital gender reassignment surgery includes
several irreversible invasive procedures for males and females and involves the
alteration of biologically healthy and functional body parts, including:
(a) For biological males:
(i) Genital reconstruction including penectomy,
which is the removal of the penis.
(ii) Orchiectomy, which is the removal of the
testicles.
(iii) Vaginoplasty, which is the construction of a
vagina-like structure, typically through a penile inversion procedure.
(iv) Clitoroplasty, which is the construction of a
clitoris-like structure.
(v) Vulvoplasty, which is the construction of a
vulva-like structure.
(b) For biological females:
(i) A hysterectomy or oophorectomy.
(ii) Reconstruction of the urethra.
(iii) Genital reconstruction including
metoidioplasty or phalloplasty, which is the construction of a penis-like
structure.
(iv) Vaginectomy, which is the removal of the
vagina.
(v) Scrotoplasty, which is the construction of a
penis-like and scrotum-like structure.
(vi) Implantation of erection or testicular
prostheses.
11. The complications, risks and long-term care
concerns associated with genital gender reassignment surgery for both males and
females are numerous and complex.
12. Nongenital gender reassignment surgery includes
various invasive procedures for males and females and also involves the
alteration or removal of biologically normal and functional body parts,
including:
(a) For biological males:
(i) Augmentation mammoplasty.
(ii) Facial feminization surgery.
(iii) Liposuction.
(iv) Lipofilling.
(v) Voice surgery.
(vi) Thyroid cartilage reduction.
(vii) Gluteal augmentation.
(viii) Hair reconstruction.
(ix) Other aesthetic procedures.
(b) For biological females:
(i) A subcutaneous mastectomy.
(ii) Voice surgery.
(iii) Liposuction.
(iv) Lipofilling.
(v) Pectoral implants.
(vi) Other aesthetic procedures.
13. It is an accepted principle of economics and
public policy that when a service or product is subsidized or reimbursed,
demand for that service or product is increased. Between 2015 and
2016, gender reassignment surgeries increased by nearly twenty percent in the
United States.
14. It is of grave concern to the legislature that
the medical community, despite the lack of studies showing that the benefits of
such extreme interventions outweigh the risks, is allowing individuals who
experience distress at identifying with their biological sex to be subjects of
irreversible and drastic nongenital gender reassignment surgery and
irreversible, permanently sterilizing genital gender reassignment surgery,
which may actually increase the risk of suicide.
Sec. 4. Short title
This act may be cited as the "Arizona's Children Deserve
Help Not Harm Act".
Sec. 5. Effective date;
purpose
A. This act is effective from and after March 31,
2023.
B. The effective date of this act is delayed so that
minors in this state who are currently using puberty-blocking drugs or
cross-sex hormones have time for appropriate medication tapering and
discontinuation under the care of the minor's physician or other health care
professional.
As enrolled or final
4,061 characters
Senate Engrossed
gender transition; prohibitions; public monies
(now:
irreversible gender reassignment surgery; minors)
State of
Arizona
Senate
Fifty-fifth
Legislature
Second Regular
Session
2022
CHAPTER
104
SENATE BILL 1138
An Act
amending
title 32, chapter 32, article 1, Arizona Revised Statutes, by adding section
32-3230; relating to health care.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 32, chapter 32, article 1,
Arizona Revised Statutes, is amended by adding section 32-3230, to read:
START_STATUTE32-3230. Prohibition of irreversible gender reassignment surgery for
minors; definitions
A. A physician may not provide
irreversible gender reassignment surgery to any individual who is under
eighteen years of age.
B. A physician may provide any of the
following to an individual who is under eighteen years of age:
1. Services to an individual born
with a medically verifiable disorder of sex development, including an
individual with external biological sex characteristics that are irresolvably
ambiguous, such as being born with forty-six XX chromosomes with virilization
or forty-six XY chromosomes with undervirilization or having both ovarian
and testicular tissue.
2. Services provided when a physician
has otherwise diagnosed a disorder of sexual development and has determined through
genetic or biochemical testing that the individual does not have normal sex
chromosome structure, sex steroid hormone production or sex steroid hormone
action.
3. The treatment of any infection,
injury, disease or disorder that has been caused by or exacerbated by the
performance of gender transition procedures, whether or not the gender
transition procedure was performed in accordance with state and federal law.
4. Any procedure undertaken because
the individual suffers from a physical disorder, physical injury or physical
illness that would, as certified by a physician, place the individual in
imminent danger of death or impairment of major bodily function unless surgery
is performed.
C. for the purposes of this section:
1. "Biological sex" means
the biological indication of male and female in the context of reproductive
potential or capacity, such as sex chromosomes, naturally occurring sex
hormones, gonads and nonambiguous internal and external genitalia present at
birth, without regard to an individual's psychological, chosen or subjective
experience of gender.
2. "Gender" means the
psychological, behavioral, social and cultural aspects of being male or female.
3. "Gender transition"
means the process in which a person goes from identifying with and living as a
gender that corresponds to the person's biological sex to identifying with and
living as a gender different from the person's biological sex and may involve
social, legal or physical changes.
4. "irreversible gender
reassignment surgery" means a medical procedure performed for the purpose
of assisting an individual with a gender transition, including any of the
following:
(a) penectomy,
orchiectomy, vaginoplasty, clitoroplasty or vulvoplasty for biologically male
patients or hysterectomy or ovariectomy for biologically female patients.
(b) metoidioplasty,
phalloplasty, vaginectomy, scrotoplasty or implantation of erection or
testicular prostheses for biologically female patients.
(c) Augmentation
mammoplasty for biologically male patients and subcutaneous mastectomy for
female patients.
5. "Physician" means a
person who is licensed pursuant to chapter 13 or 17 of this title. END_STATUTE
Sec. 2. Effective date
This act is effective from and after March 31, 2023.
APPROVED BY THE GOVERNOR MARCH 30, 2022.
FILED IN THE OFFICE OF THE SECRETARY OF STATE MARCH 30, 2022.